IAnthus Capital Earnings Estimate
IAnthus Capital Earnings per Share Projection vs Actual
About IAnthus Capital Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of IAnthus Capital earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current IAnthus Capital estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as IAnthus Capital fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. The company was founded in 2014 and is headquartered in New York, New York. Ianthus Capital operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in IAnthus Pink Sheet
IAnthus Capital financial ratios help investors to determine whether IAnthus Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in IAnthus with respect to the benefits of owning IAnthus Capital security.